Compare MRVI & DIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRVI | DIN |
|---|---|---|
| Founded | 2014 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 449.6M | 491.1M |
| IPO Year | 2020 | 1991 |
| Metric | MRVI | DIN |
|---|---|---|
| Price | $3.20 | $32.24 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 6 |
| Target Price | $4.57 | ★ $26.67 |
| AVG Volume (30 Days) | ★ 1.2M | 458.6K |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 2.40% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.24 |
| Revenue | $192,435,000.00 | ★ $866,500,000.00 |
| Revenue This Year | N/A | $10.69 |
| Revenue Next Year | $9.04 | $2.20 |
| P/E Ratio | ★ N/A | $14.15 |
| Revenue Growth | N/A | ★ 6.47 |
| 52 Week Low | $1.67 | $18.63 |
| 52 Week High | $6.21 | $35.34 |
| Indicator | MRVI | DIN |
|---|---|---|
| Relative Strength Index (RSI) | 41.04 | 50.85 |
| Support Level | $3.21 | $32.44 |
| Resistance Level | $3.37 | $34.22 |
| Average True Range (ATR) | 0.16 | 1.05 |
| MACD | -0.05 | -0.49 |
| Stochastic Oscillator | 5.95 | 23.54 |
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
Dine Brands Global Inc owns and franchises thousands of restaurants under the Applebee's and International House of Pancakes names. Almost all company restaurants are located in the United States and franchised. Royalty revenue, which the company gets from franchisees based on franchisees' sales, accounts for roughly three-quarters of total company revenue. The company also earns revenue by leasing restaurant sites to franchisees. The company has four reportable segments Franchise operations, (an aggregation of Applebee's and IHOP franchise operations), Rental operations, Financing operations and Company-operated restaurant operations. The majority of revenue is derived from the Franchise operations segment.